Found 144 clinical trials
A Phase 1 Study Exploring the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Select Advanced Solid Tumors
The purpose of this study is to evaluate the safety and tolerability, pharmacokinetics, pharmacodynamics, and early clinical activity of INCB099280 in participants with select solid tumors
- 0 views
- 28 Oct, 2022
- 13 locations
Effects of N-Acetyl-L-Leucine on Niemann-Pick Disease Type C (NPC): A Phase III, Randomized, Placebo-controlled, Double-blind, Crossover Study
A pivotal, randomized, double-blind, placebo controlled, multi-center therapeutic study for patients age 4 and older with a confirmed diagnosis of Niemann Pick disease type C (NPC). The
- 0 views
- 27 Oct, 2022
- 11 locations
NPC - AXEL Study : Axitinib-Avelumab
Nasopharyngeal cancer (NPC) is the most common head and neck cancer in South China and South East Asia. Worldwide, there are 80,000 incident cases and 50,000 deaths annually. In Hong Kong, NPC
- 0 views
- 04 Oct, 2022
- 1 location
CNS10-NPC for the Treatment of RP
are called "CNS10-NPC." The investigational treatment has been tested in animals, but it has not yet been tested in people. In this study, the investigators want to learn if CNS10-NPC cells are safe
- 257 views
- 28 Feb, 2022
- 1 location
Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma
cisplatin concurrent chemoradiotherapy alone in treating patients with locoregionally recurrent nasopharyngeal carcinoma.
- 0 views
- 26 Jul, 2021
- 1 location
ICCRT vs. CRT for Locally Advanced Nasopharyngeal Carcinoma
concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma.
- 0 views
- 07 Oct, 2021
- 1 location
NPC-06 to Pain Associated With Acute Herpes Zoster
To confirm the pain relief effect and the safety of NPC-06 (fosphenytoin sodium hydrate) in patients with pain associated with acute herpes zoster in a placebo-controlled, double-blind, parallel
- 1 views
- 07 Oct, 2022
- 10 locations
Combining RT With Toripalimab and Chemotherapy in Metastatic Nasopharyngeal Carcinoma
Incidences of de novo metastatic nasopharyngeal carcinoma range from 6% to 8% at the time of presentation. For the initial diagnosis of metastatic NPC, PD-1 plus chemotherapy yields a
- 0 views
- 07 Jun, 2022
- 1 location
Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC
A Prospective, Single-arm, Multicenter Clinical Study of Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent Nasopharyngeal Carcinoma
- 0 views
- 29 May, 2022
- 1 location
Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal Carcinoma
nasopharyngeal carcinoma.
- 0 views
- 01 Mar, 2022
- 1 location